Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation.
O'Donghaile D, Kelley W, Klein HG, Flegel WA.
Transfusion. 2012 Feb;52(2):456-8. doi: 10.1111/j.1537-2995.2011.03465.x. No abstract available.
Related citations
Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk hematologic malignancies.
Huang W, Li H, Gao C, Bo J, Wang Q, Zhao Y, Jing Y, Wang S, Zhu H, Dou L, Wang L, Yu L.
Transfusion. 2012 Jan 10. doi: 10.1111/j.1537-2995.2011.03478.x. [Epub ahead of print]
Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning.
Worel N, Böhm A, Rabitsch W, Leitner G, Mitterbauer M, Kalhs P, Mayr WR, Schwartz D, Greinix HT.
Transfusion. 2011 Dec 1. doi: 10.1111/j.1537-2995.2011.03457.x. [Epub ahead of print]
Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J, Fan H, Hao J, Ren Y, Chen L, Li G, Xie R, Yang Y, Qian K, Liu M.
Transfusion. 2011 Nov 21. doi: 10.1111/j.1537-2995.2011.03448.x. [Epub ahead of print]
Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation.
Vetlesen A, Holme PA, Lyberg T, Kjeldsen-Kragh J.
Transfusion. 2011 Nov 16. doi: 10.1111/j.1537-2995.2011.03442.x. [Epub ahead of print]
Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems.
Brauninger S, Bialleck H, Thorausch K, Felt T, Seifried E, Bonig H.
Transfusion. 2012 May;52(5):1137-45. doi: 10.1111/j.1537-2995.2011.03414.x. Epub 2011 Nov 2.
Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation.
Bárcena A, Muench MO, Kapidzic M, Gormley M, Goldfien GA, Fisher SJ.
Transfusion. 2011 Nov;51 Suppl 4:94S-105S. doi: 10.1111/j.1537-2995.2011.03372.x.
Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system.
Jiang S, Fu Y, Avraham HK.
Transfusion. 2011 Nov;51 Suppl 4:65S-71S. doi: 10.1111/j.1537-2995.2011.03368.x.
On how Rac controls hematopoietic stem cell activity.
Cancelas JA.
Transfusion. 2011 Nov;51 Suppl 4:153S-159S. doi: 10.1111/j.1537-2995.2011.03378.x.
Human embryonic stem cell-derived mesenchymal stromal cells.
Hematti P.
Transfusion. 2011 Nov;51 Suppl 4:138S-144S. doi: 10.1111/j.1537-2995.2011.03376.x.
Understanding the first steps in embryonic stem cell exit from the pluripotent state.
Luckey CJ, Lu Y, Marto JA.
Transfusion. 2011 Nov;51 Suppl 4:118S-124S. doi: 10.1111/j.1537-2995.2011.03374.x.
A journey to produce platelets in vitro.
Reems JA.
Transfusion. 2011 Nov;51 Suppl 4:169S-176S. doi: 10.1111/j.1537-2995.2011.03380.x.
Production of cytotoxic, KIR-negative NK cells from CD34+ cord blood cells with the use of Notch signaling.
Beck RC.
Transfusion. 2011 Nov;51 Suppl 4:145S-152S. doi: 10.1111/j.1537-2995.2011.03377.x.
Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics.
Jimenez A, Fung HC, Christopherson KW 2nd.
Transfusion. 2011 Nov;51 Suppl 4:125S-137S. doi: 10.1111/j.1537-2995.2011.03375.x.
Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation.
Sánchez-Guijo FM, López-Villar O, López-Anglada L, Villarón EM, Muntión S, Díez-Campelo M, Perez-Simón JA, San Miguel JF, Caballero D, Del Cañizo MC.
Transfusion. 2012 May;52(5):1086-91. doi: 10.1111/j.1537-2995.2011.03400.x. Epub 2011 Oct 24.
Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood.
Gilstad C, Roschewski M, Wells J, Delmas A, Lackey J, Uribe P, Popa C, Jardeleza T, Roop S.
Transfusion. 2012 May;52(5):930-5. doi: 10.1111/j.1537-2995.2011.03365.x. Epub 2011 Oct 7.
Risk factors for microbial contamination of peripheral blood stem cell products.
Donmez A, Aydemir S, Arik B, Tunger A, Cilli F, Orman M, Tombuloglu M.
Transfusion. 2012 Apr;52(4):777-81. doi: 10.1111/j.1537-2995.2011.03359.x. Epub 2011 Oct 7.
Relationship of CD34+ cells infused and red blood cell transfusion requirements after autologous peripheral blood stem cell transplants: a novel method of analysis.
Dunlop LC, Heller GZ.
Transfusion. 2012 Apr;52(4):782-6. doi: 10.1111/j.1537-2995.2011.03360.x. Epub 2011 Oct 6.
Postthaw filtration of umbilical cord blood does not affect product quality or likelihood of engraftment.
Totoe G, Lindgren B, Emrick E, Kadidlo D, McKenna D.
Transfusion. 2011 Oct;51(10):2257-8. doi: 10.1111/j.1537-2995.2011.03256.x. No abstract available.
Cord (placental) blood storage: extent and functional aspects.
Ivanovic Z, Rodriguez L, Mazic S, Duchez P, Dazey B, Lafarge X, Vlaski M, Boiron JM.
Transfusion. 2011 Sep;51(9):2044-5; author reply 2045-7. doi: 10.1111/j.1537-2995.2011.03227.x. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on